nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—TSPO—oviduct—ovarian cancer	0.028	0.201	CbGeAlD
Lorazepam—UGT2B15—female reproductive system—ovarian cancer	0.0146	0.105	CbGeAlD
Lorazepam—TSPO—myometrium—ovarian cancer	0.00894	0.0642	CbGeAlD
Lorazepam—TSPO—embryo—ovarian cancer	0.0086	0.0618	CbGeAlD
Lorazepam—TSPO—epithelium—ovarian cancer	0.00702	0.0504	CbGeAlD
Lorazepam—TSPO—uterine cervix—ovarian cancer	0.00696	0.05	CbGeAlD
Lorazepam—TSPO—decidua—ovarian cancer	0.00663	0.0476	CbGeAlD
Lorazepam—TSPO—endometrium—ovarian cancer	0.00629	0.0452	CbGeAlD
Lorazepam—TSPO—gonad—ovarian cancer	0.00584	0.0419	CbGeAlD
Lorazepam—TSPO—uterus—ovarian cancer	0.0058	0.0416	CbGeAlD
Lorazepam—GABRB3—gonad—ovarian cancer	0.0053	0.0381	CbGeAlD
Lorazepam—TSPO—female reproductive system—ovarian cancer	0.00521	0.0374	CbGeAlD
Lorazepam—TSPO—bone marrow—ovarian cancer	0.00492	0.0353	CbGeAlD
Lorazepam—TSPO—female gonad—ovarian cancer	0.00474	0.0341	CbGeAlD
Lorazepam—GABRB3—female reproductive system—ovarian cancer	0.00473	0.034	CbGeAlD
Lorazepam—TSPO—vagina—ovarian cancer	0.00472	0.0339	CbGeAlD
Lorazepam—TSPO—testis—ovarian cancer	0.00421	0.0302	CbGeAlD
Lorazepam—GABRB3—testis—ovarian cancer	0.00382	0.0274	CbGeAlD
Lorazepam—TSPO—lymph node—ovarian cancer	0.00305	0.0219	CbGeAlD
Lorazepam—Diclofenac—CXCL8—ovarian cancer	0.00297	0.377	CrCbGaD
Lorazepam—Alopecia—Vinorelbine—ovarian cancer	0.00247	0.00289	CcSEcCtD
Lorazepam—Erythema—Vinorelbine—ovarian cancer	0.00243	0.00285	CcSEcCtD
Lorazepam—Visual disturbance—Docetaxel—ovarian cancer	0.00243	0.00285	CcSEcCtD
Lorazepam—Injection site pain—Doxorubicin—ovarian cancer	0.00242	0.00284	CcSEcCtD
Lorazepam—Convulsion—Melphalan—ovarian cancer	0.00241	0.00283	CcSEcCtD
Lorazepam—Liver injury—Doxorubicin—ovarian cancer	0.00235	0.00276	CcSEcCtD
Lorazepam—Lethargy—Docetaxel—ovarian cancer	0.00235	0.00275	CcSEcCtD
Lorazepam—Thinking abnormal—Epirubicin—ovarian cancer	0.00234	0.00274	CcSEcCtD
Lorazepam—Hyponatraemia—Docetaxel—ovarian cancer	0.00231	0.00271	CcSEcCtD
Lorazepam—Infection—Topotecan—ovarian cancer	0.0023	0.0027	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.0023	0.0027	CcSEcCtD
Lorazepam—Delirium—Doxorubicin—ovarian cancer	0.0023	0.0027	CcSEcCtD
Lorazepam—Thrombocytopenia—Topotecan—ovarian cancer	0.00227	0.00266	CcSEcCtD
Lorazepam—Dysarthria—Epirubicin—ovarian cancer	0.00226	0.00265	CcSEcCtD
Lorazepam—Infection—Melphalan—ovarian cancer	0.00226	0.00265	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00225	0.00264	CcSEcCtD
Lorazepam—Fatigue—Chlorambucil—ovarian cancer	0.00225	0.00263	CcSEcCtD
Lorazepam—Pancytopenia—Paclitaxel—ovarian cancer	0.00223	0.00261	CcSEcCtD
Lorazepam—Pain—Chlorambucil—ovarian cancer	0.00223	0.00261	CcSEcCtD
Lorazepam—Thrombocytopenia—Melphalan—ovarian cancer	0.00222	0.00261	CcSEcCtD
Lorazepam—Tachycardia—Melphalan—ovarian cancer	0.00222	0.0026	CcSEcCtD
Lorazepam—Atrioventricular block—Epirubicin—ovarian cancer	0.0022	0.00259	CcSEcCtD
Lorazepam—Vertigo—Vinorelbine—ovarian cancer	0.00218	0.00256	CcSEcCtD
Lorazepam—Ataxia—Docetaxel—ovarian cancer	0.00216	0.00254	CcSEcCtD
Lorazepam—Thinking abnormal—Doxorubicin—ovarian cancer	0.00216	0.00253	CcSEcCtD
Lorazepam—Feeling abnormal—Chlorambucil—ovarian cancer	0.00215	0.00252	CcSEcCtD
Lorazepam—Hepatocellular injury—Epirubicin—ovarian cancer	0.00214	0.00251	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Epirubicin—ovarian cancer	0.00214	0.00251	CcSEcCtD
Lorazepam—Injection site reaction—Epirubicin—ovarian cancer	0.00213	0.00249	CcSEcCtD
Lorazepam—Liver function test abnormal—Docetaxel—ovarian cancer	0.00213	0.00249	CcSEcCtD
Lorazepam—Hypotension—Melphalan—ovarian cancer	0.00212	0.00249	CcSEcCtD
Lorazepam—Hypertension—Vinorelbine—ovarian cancer	0.0021	0.00246	CcSEcCtD
Lorazepam—Dysarthria—Doxorubicin—ovarian cancer	0.00209	0.00245	CcSEcCtD
Lorazepam—Cystitis noninfective—Epirubicin—ovarian cancer	0.00209	0.00245	CcSEcCtD
Lorazepam—Salivary hypersecretion—Epirubicin—ovarian cancer	0.00208	0.00244	CcSEcCtD
Lorazepam—Cystitis—Epirubicin—ovarian cancer	0.00207	0.00242	CcSEcCtD
Lorazepam—Atrioventricular block—Doxorubicin—ovarian cancer	0.00204	0.00239	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Topotecan—ovarian cancer	0.002	0.00235	CcSEcCtD
Lorazepam—Fatigue—Topotecan—ovarian cancer	0.002	0.00235	CcSEcCtD
Lorazepam—Pain—Topotecan—ovarian cancer	0.00198	0.00233	CcSEcCtD
Lorazepam—Constipation—Topotecan—ovarian cancer	0.00198	0.00233	CcSEcCtD
Lorazepam—Hepatocellular injury—Doxorubicin—ovarian cancer	0.00198	0.00232	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.00198	0.00232	CcSEcCtD
Lorazepam—Infection—Vinorelbine—ovarian cancer	0.00197	0.00231	CcSEcCtD
Lorazepam—Injection site reaction—Doxorubicin—ovarian cancer	0.00197	0.00231	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00196	0.0023	CcSEcCtD
Lorazepam—Fatigue—Melphalan—ovarian cancer	0.00196	0.0023	CcSEcCtD
Lorazepam—Coma—Epirubicin—ovarian cancer	0.00195	0.00229	CcSEcCtD
Lorazepam—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00194	0.00228	CcSEcCtD
Lorazepam—Pain—Melphalan—ovarian cancer	0.00194	0.00228	CcSEcCtD
Lorazepam—Tachycardia—Vinorelbine—ovarian cancer	0.00194	0.00227	CcSEcCtD
Lorazepam—Bladder pain—Epirubicin—ovarian cancer	0.00193	0.00227	CcSEcCtD
Lorazepam—Cystitis noninfective—Doxorubicin—ovarian cancer	0.00193	0.00227	CcSEcCtD
Lorazepam—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.00192	0.00225	CcSEcCtD
Lorazepam—Hypersensitivity—Chlorambucil—ovarian cancer	0.00192	0.00225	CcSEcCtD
Lorazepam—Bradycardia—Paclitaxel—ovarian cancer	0.00191	0.00224	CcSEcCtD
Lorazepam—Feeling abnormal—Topotecan—ovarian cancer	0.00191	0.00224	CcSEcCtD
Lorazepam—Cystitis—Doxorubicin—ovarian cancer	0.00191	0.00224	CcSEcCtD
Lorazepam—Pulmonary oedema—Epirubicin—ovarian cancer	0.0019	0.00223	CcSEcCtD
Lorazepam—Pancytopenia—Docetaxel—ovarian cancer	0.00189	0.00222	CcSEcCtD
Lorazepam—Asthenia—Chlorambucil—ovarian cancer	0.00187	0.00219	CcSEcCtD
Lorazepam—Mental disability—Epirubicin—ovarian cancer	0.00186	0.00218	CcSEcCtD
Lorazepam—Hypotension—Vinorelbine—ovarian cancer	0.00185	0.00217	CcSEcCtD
Lorazepam—Visual impairment—Paclitaxel—ovarian cancer	0.00181	0.00212	CcSEcCtD
Lorazepam—Coma—Doxorubicin—ovarian cancer	0.00181	0.00212	CcSEcCtD
Lorazepam—Bladder pain—Doxorubicin—ovarian cancer	0.00179	0.0021	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.00178	0.00209	CcSEcCtD
Lorazepam—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00176	0.00207	CcSEcCtD
Lorazepam—Jaundice—Docetaxel—ovarian cancer	0.00173	0.00203	CcSEcCtD
Lorazepam—Mental disability—Doxorubicin—ovarian cancer	0.00172	0.00201	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00171	0.00201	CcSEcCtD
Lorazepam—Fatigue—Vinorelbine—ovarian cancer	0.00171	0.00201	CcSEcCtD
Lorazepam—Hypersensitivity—Topotecan—ovarian cancer	0.00171	0.002	CcSEcCtD
Lorazepam—Pain—Vinorelbine—ovarian cancer	0.0017	0.00199	CcSEcCtD
Lorazepam—Constipation—Vinorelbine—ovarian cancer	0.0017	0.00199	CcSEcCtD
Lorazepam—Chills—Paclitaxel—ovarian cancer	0.00169	0.00198	CcSEcCtD
Lorazepam—Arrhythmia—Paclitaxel—ovarian cancer	0.00168	0.00197	CcSEcCtD
Lorazepam—Hypersensitivity—Melphalan—ovarian cancer	0.00167	0.00196	CcSEcCtD
Lorazepam—Asthenia—Topotecan—ovarian cancer	0.00166	0.00195	CcSEcCtD
Lorazepam—Alopecia—Paclitaxel—ovarian cancer	0.00166	0.00195	CcSEcCtD
Lorazepam—Vomiting—Chlorambucil—ovarian cancer	0.00166	0.00194	CcSEcCtD
Lorazepam—Agranulocytosis—Docetaxel—ovarian cancer	0.00166	0.00194	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00165	0.00194	CcSEcCtD
Lorazepam—Erythema—Paclitaxel—ovarian cancer	0.00164	0.00192	CcSEcCtD
Lorazepam—Feeling abnormal—Vinorelbine—ovarian cancer	0.00164	0.00192	CcSEcCtD
Lorazepam—Asthenia—Melphalan—ovarian cancer	0.00163	0.00191	CcSEcCtD
Lorazepam—Tension—Paclitaxel—ovarian cancer	0.0016	0.00188	CcSEcCtD
Lorazepam—Nervousness—Paclitaxel—ovarian cancer	0.00159	0.00186	CcSEcCtD
Lorazepam—Lethargy—Epirubicin—ovarian cancer	0.00158	0.00186	CcSEcCtD
Lorazepam—Hyponatraemia—Epirubicin—ovarian cancer	0.00156	0.00183	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00155	0.00182	CcSEcCtD
Lorazepam—Osteoarthritis—Epirubicin—ovarian cancer	0.00155	0.00182	CcSEcCtD
Lorazepam—Diplopia—Epirubicin—ovarian cancer	0.00155	0.00182	CcSEcCtD
Lorazepam—Nausea—Chlorambucil—ovarian cancer	0.00155	0.00181	CcSEcCtD
Lorazepam—Vision blurred—Paclitaxel—ovarian cancer	0.00154	0.00181	CcSEcCtD
Lorazepam—Visual impairment—Docetaxel—ovarian cancer	0.00153	0.0018	CcSEcCtD
Lorazepam—Dizziness—Topotecan—ovarian cancer	0.00153	0.0018	CcSEcCtD
Lorazepam—Tremor—Paclitaxel—ovarian cancer	0.00153	0.0018	CcSEcCtD
Lorazepam—Agitation—Paclitaxel—ovarian cancer	0.0015	0.00176	CcSEcCtD
Lorazepam—Cardiac arrest—Epirubicin—ovarian cancer	0.00148	0.00173	CcSEcCtD
Lorazepam—Vomiting—Topotecan—ovarian cancer	0.00147	0.00173	CcSEcCtD
Lorazepam—Vertigo—Paclitaxel—ovarian cancer	0.00147	0.00172	CcSEcCtD
Lorazepam—Lethargy—Doxorubicin—ovarian cancer	0.00147	0.00172	CcSEcCtD
Lorazepam—Rash—Topotecan—ovarian cancer	0.00146	0.00172	CcSEcCtD
Lorazepam—Hypersensitivity—Vinorelbine—ovarian cancer	0.00146	0.00171	CcSEcCtD
Lorazepam—Dermatitis—Topotecan—ovarian cancer	0.00146	0.00171	CcSEcCtD
Lorazepam—Ataxia—Epirubicin—ovarian cancer	0.00146	0.00171	CcSEcCtD
Lorazepam—Headache—Topotecan—ovarian cancer	0.00145	0.0017	CcSEcCtD
Lorazepam—Vomiting—Melphalan—ovarian cancer	0.00144	0.00169	CcSEcCtD
Lorazepam—Hyponatraemia—Doxorubicin—ovarian cancer	0.00144	0.00169	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00144	0.00168	CcSEcCtD
Lorazepam—Osteoarthritis—Doxorubicin—ovarian cancer	0.00144	0.00168	CcSEcCtD
Lorazepam—Diplopia—Doxorubicin—ovarian cancer	0.00144	0.00168	CcSEcCtD
Lorazepam—Liver function test abnormal—Epirubicin—ovarian cancer	0.00143	0.00168	CcSEcCtD
Lorazepam—Rash—Melphalan—ovarian cancer	0.00143	0.00168	CcSEcCtD
Lorazepam—Dermatitis—Melphalan—ovarian cancer	0.00143	0.00168	CcSEcCtD
Lorazepam—Chills—Docetaxel—ovarian cancer	0.00143	0.00168	CcSEcCtD
Lorazepam—Asthenia—Vinorelbine—ovarian cancer	0.00142	0.00167	CcSEcCtD
Lorazepam—Arrhythmia—Docetaxel—ovarian cancer	0.00142	0.00167	CcSEcCtD
Lorazepam—Convulsion—Paclitaxel—ovarian cancer	0.00142	0.00166	CcSEcCtD
Lorazepam—Hypertension—Paclitaxel—ovarian cancer	0.00141	0.00166	CcSEcCtD
Lorazepam—Alopecia—Docetaxel—ovarian cancer	0.00141	0.00165	CcSEcCtD
Lorazepam—Erythema—Docetaxel—ovarian cancer	0.00139	0.00163	CcSEcCtD
Lorazepam—Nausea—Topotecan—ovarian cancer	0.00138	0.00162	CcSEcCtD
Lorazepam—Cardiac arrest—Doxorubicin—ovarian cancer	0.00137	0.0016	CcSEcCtD
Lorazepam—Dry mouth—Paclitaxel—ovarian cancer	0.00136	0.0016	CcSEcCtD
Lorazepam—Clozapine—CYP1B1—ovarian cancer	0.00135	0.172	CrCbGaD
Lorazepam—Ataxia—Doxorubicin—ovarian cancer	0.00135	0.00158	CcSEcCtD
Lorazepam—Nausea—Melphalan—ovarian cancer	0.00135	0.00158	CcSEcCtD
Lorazepam—Confusional state—Paclitaxel—ovarian cancer	0.00135	0.00158	CcSEcCtD
Lorazepam—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00133	0.00156	CcSEcCtD
Lorazepam—Infection—Paclitaxel—ovarian cancer	0.00133	0.00155	CcSEcCtD
Lorazepam—Dizziness—Vinorelbine—ovarian cancer	0.00131	0.00154	CcSEcCtD
Lorazepam—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00131	0.00153	CcSEcCtD
Lorazepam—Tachycardia—Paclitaxel—ovarian cancer	0.0013	0.00153	CcSEcCtD
Lorazepam—Pancytopenia—Epirubicin—ovarian cancer	0.00127	0.00149	CcSEcCtD
Lorazepam—Vomiting—Vinorelbine—ovarian cancer	0.00126	0.00148	CcSEcCtD
Lorazepam—Rash—Vinorelbine—ovarian cancer	0.00125	0.00147	CcSEcCtD
Lorazepam—Dermatitis—Vinorelbine—ovarian cancer	0.00125	0.00147	CcSEcCtD
Lorazepam—Hypotension—Paclitaxel—ovarian cancer	0.00125	0.00146	CcSEcCtD
Lorazepam—Headache—Vinorelbine—ovarian cancer	0.00124	0.00146	CcSEcCtD
Lorazepam—Convulsion—Docetaxel—ovarian cancer	0.0012	0.00141	CcSEcCtD
Lorazepam—Hypertension—Docetaxel—ovarian cancer	0.0012	0.0014	CcSEcCtD
Lorazepam—Drowsiness—Epirubicin—ovarian cancer	0.0012	0.0014	CcSEcCtD
Lorazepam—Somnolence—Paclitaxel—ovarian cancer	0.00119	0.00139	CcSEcCtD
Lorazepam—Pancytopenia—Doxorubicin—ovarian cancer	0.00118	0.00138	CcSEcCtD
Lorazepam—Nausea—Vinorelbine—ovarian cancer	0.00118	0.00138	CcSEcCtD
Lorazepam—Jaundice—Epirubicin—ovarian cancer	0.00117	0.00137	CcSEcCtD
Lorazepam—Dry mouth—Docetaxel—ovarian cancer	0.00115	0.00135	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00115	0.00135	CcSEcCtD
Lorazepam—Fatigue—Paclitaxel—ovarian cancer	0.00115	0.00135	CcSEcCtD
Lorazepam—Constipation—Paclitaxel—ovarian cancer	0.00114	0.00134	CcSEcCtD
Lorazepam—Pain—Paclitaxel—ovarian cancer	0.00114	0.00134	CcSEcCtD
Lorazepam—Confusional state—Docetaxel—ovarian cancer	0.00114	0.00134	CcSEcCtD
Lorazepam—Infection—Docetaxel—ovarian cancer	0.00112	0.00132	CcSEcCtD
Lorazepam—Agranulocytosis—Epirubicin—ovarian cancer	0.00112	0.00131	CcSEcCtD
Lorazepam—Thrombocytopenia—Docetaxel—ovarian cancer	0.00111	0.0013	CcSEcCtD
Lorazepam—Drowsiness—Doxorubicin—ovarian cancer	0.00111	0.0013	CcSEcCtD
Lorazepam—Tachycardia—Docetaxel—ovarian cancer	0.0011	0.00129	CcSEcCtD
Lorazepam—Feeling abnormal—Paclitaxel—ovarian cancer	0.0011	0.00129	CcSEcCtD
Lorazepam—Bradycardia—Epirubicin—ovarian cancer	0.00109	0.00128	CcSEcCtD
Lorazepam—Jaundice—Doxorubicin—ovarian cancer	0.00108	0.00127	CcSEcCtD
Lorazepam—Hypotension—Docetaxel—ovarian cancer	0.00106	0.00124	CcSEcCtD
Lorazepam—Visual impairment—Epirubicin—ovarian cancer	0.00104	0.00121	CcSEcCtD
Lorazepam—Agranulocytosis—Doxorubicin—ovarian cancer	0.00103	0.00121	CcSEcCtD
Lorazepam—Bradycardia—Doxorubicin—ovarian cancer	0.00101	0.00119	CcSEcCtD
Lorazepam—Somnolence—Docetaxel—ovarian cancer	0.00101	0.00118	CcSEcCtD
Lorazepam—Hypersensitivity—Paclitaxel—ovarian cancer	0.000983	0.00115	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000977	0.00115	CcSEcCtD
Lorazepam—Fatigue—Docetaxel—ovarian cancer	0.000975	0.00114	CcSEcCtD
Lorazepam—Pain—Docetaxel—ovarian cancer	0.000967	0.00113	CcSEcCtD
Lorazepam—Constipation—Docetaxel—ovarian cancer	0.000967	0.00113	CcSEcCtD
Lorazepam—Chills—Epirubicin—ovarian cancer	0.000964	0.00113	CcSEcCtD
Lorazepam—Arrhythmia—Epirubicin—ovarian cancer	0.000959	0.00113	CcSEcCtD
Lorazepam—Visual impairment—Doxorubicin—ovarian cancer	0.000958	0.00112	CcSEcCtD
Lorazepam—Asthenia—Paclitaxel—ovarian cancer	0.000958	0.00112	CcSEcCtD
Lorazepam—Alopecia—Epirubicin—ovarian cancer	0.000949	0.00111	CcSEcCtD
Lorazepam—Erythema—Epirubicin—ovarian cancer	0.000935	0.0011	CcSEcCtD
Lorazepam—Feeling abnormal—Docetaxel—ovarian cancer	0.000932	0.00109	CcSEcCtD
Lorazepam—Tension—Epirubicin—ovarian cancer	0.000918	0.00108	CcSEcCtD
Lorazepam—Nervousness—Epirubicin—ovarian cancer	0.000908	0.00106	CcSEcCtD
Lorazepam—Chills—Doxorubicin—ovarian cancer	0.000892	0.00105	CcSEcCtD
Lorazepam—Arrhythmia—Doxorubicin—ovarian cancer	0.000888	0.00104	CcSEcCtD
Lorazepam—Dizziness—Paclitaxel—ovarian cancer	0.000883	0.00103	CcSEcCtD
Lorazepam—Vision blurred—Epirubicin—ovarian cancer	0.000881	0.00103	CcSEcCtD
Lorazepam—Alopecia—Doxorubicin—ovarian cancer	0.000878	0.00103	CcSEcCtD
Lorazepam—Erythema—Doxorubicin—ovarian cancer	0.000865	0.00101	CcSEcCtD
Lorazepam—Agitation—Epirubicin—ovarian cancer	0.000859	0.00101	CcSEcCtD
Lorazepam—Tension—Doxorubicin—ovarian cancer	0.000849	0.000995	CcSEcCtD
Lorazepam—Vomiting—Paclitaxel—ovarian cancer	0.000849	0.000995	CcSEcCtD
Lorazepam—Rash—Paclitaxel—ovarian cancer	0.000842	0.000987	CcSEcCtD
Lorazepam—Dermatitis—Paclitaxel—ovarian cancer	0.000841	0.000986	CcSEcCtD
Lorazepam—Nervousness—Doxorubicin—ovarian cancer	0.00084	0.000985	CcSEcCtD
Lorazepam—Vertigo—Epirubicin—ovarian cancer	0.00084	0.000985	CcSEcCtD
Lorazepam—Headache—Paclitaxel—ovarian cancer	0.000836	0.00098	CcSEcCtD
Lorazepam—Hypersensitivity—Docetaxel—ovarian cancer	0.000834	0.000977	CcSEcCtD
Lorazepam—Vision blurred—Doxorubicin—ovarian cancer	0.000815	0.000956	CcSEcCtD
Lorazepam—Asthenia—Docetaxel—ovarian cancer	0.000812	0.000952	CcSEcCtD
Lorazepam—Convulsion—Epirubicin—ovarian cancer	0.00081	0.00095	CcSEcCtD
Lorazepam—Hypertension—Epirubicin—ovarian cancer	0.000807	0.000947	CcSEcCtD
Lorazepam—Agitation—Doxorubicin—ovarian cancer	0.000795	0.000932	CcSEcCtD
Lorazepam—Nausea—Paclitaxel—ovarian cancer	0.000793	0.00093	CcSEcCtD
Lorazepam—Dry mouth—Epirubicin—ovarian cancer	0.000778	0.000913	CcSEcCtD
Lorazepam—Vertigo—Doxorubicin—ovarian cancer	0.000777	0.000911	CcSEcCtD
Lorazepam—Confusional state—Epirubicin—ovarian cancer	0.000769	0.000902	CcSEcCtD
Lorazepam—Infection—Epirubicin—ovarian cancer	0.000758	0.000889	CcSEcCtD
Lorazepam—Convulsion—Doxorubicin—ovarian cancer	0.00075	0.000879	CcSEcCtD
Lorazepam—Dizziness—Docetaxel—ovarian cancer	0.000748	0.000877	CcSEcCtD
Lorazepam—Thrombocytopenia—Epirubicin—ovarian cancer	0.000747	0.000876	CcSEcCtD
Lorazepam—Hypertension—Doxorubicin—ovarian cancer	0.000747	0.000876	CcSEcCtD
Lorazepam—Tachycardia—Epirubicin—ovarian cancer	0.000745	0.000873	CcSEcCtD
Lorazepam—Diclofenac—ABCB1—ovarian cancer	0.000736	0.0934	CrCbGaD
Lorazepam—Dry mouth—Doxorubicin—ovarian cancer	0.00072	0.000845	CcSEcCtD
Lorazepam—Vomiting—Docetaxel—ovarian cancer	0.000719	0.000843	CcSEcCtD
Lorazepam—Rash—Docetaxel—ovarian cancer	0.000713	0.000836	CcSEcCtD
Lorazepam—Hypotension—Epirubicin—ovarian cancer	0.000713	0.000836	CcSEcCtD
Lorazepam—Dermatitis—Docetaxel—ovarian cancer	0.000713	0.000836	CcSEcCtD
Lorazepam—Confusional state—Doxorubicin—ovarian cancer	0.000712	0.000835	CcSEcCtD
Lorazepam—Headache—Docetaxel—ovarian cancer	0.000709	0.000831	CcSEcCtD
Lorazepam—Infection—Doxorubicin—ovarian cancer	0.000701	0.000822	CcSEcCtD
Lorazepam—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000691	0.000811	CcSEcCtD
Lorazepam—Tachycardia—Doxorubicin—ovarian cancer	0.000689	0.000808	CcSEcCtD
Lorazepam—Somnolence—Epirubicin—ovarian cancer	0.000678	0.000795	CcSEcCtD
Lorazepam—Nausea—Docetaxel—ovarian cancer	0.000672	0.000788	CcSEcCtD
Lorazepam—Hypotension—Doxorubicin—ovarian cancer	0.00066	0.000774	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000659	0.000772	CcSEcCtD
Lorazepam—Fatigue—Epirubicin—ovarian cancer	0.000658	0.000771	CcSEcCtD
Lorazepam—Constipation—Epirubicin—ovarian cancer	0.000653	0.000765	CcSEcCtD
Lorazepam—Pain—Epirubicin—ovarian cancer	0.000653	0.000765	CcSEcCtD
Lorazepam—Feeling abnormal—Epirubicin—ovarian cancer	0.000629	0.000737	CcSEcCtD
Lorazepam—Somnolence—Doxorubicin—ovarian cancer	0.000628	0.000736	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00061	0.000715	CcSEcCtD
Lorazepam—Fatigue—Doxorubicin—ovarian cancer	0.000609	0.000714	CcSEcCtD
Lorazepam—Pain—Doxorubicin—ovarian cancer	0.000604	0.000708	CcSEcCtD
Lorazepam—Constipation—Doxorubicin—ovarian cancer	0.000604	0.000708	CcSEcCtD
Lorazepam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000582	0.000682	CcSEcCtD
Lorazepam—Hypersensitivity—Epirubicin—ovarian cancer	0.000562	0.000659	CcSEcCtD
Lorazepam—Nitrazepam—ABCB1—ovarian cancer	0.000556	0.0706	CrCbGaD
Lorazepam—Asthenia—Epirubicin—ovarian cancer	0.000547	0.000642	CcSEcCtD
Lorazepam—Chlorprothixene—ABCB1—ovarian cancer	0.00053	0.0673	CrCbGaD
Lorazepam—Hypersensitivity—Doxorubicin—ovarian cancer	0.00052	0.00061	CcSEcCtD
Lorazepam—Asthenia—Doxorubicin—ovarian cancer	0.000507	0.000594	CcSEcCtD
Lorazepam—Dizziness—Epirubicin—ovarian cancer	0.000505	0.000592	CcSEcCtD
Lorazepam—Flurazepam—ABCB1—ovarian cancer	0.000495	0.0628	CrCbGaD
Lorazepam—Vomiting—Epirubicin—ovarian cancer	0.000485	0.000569	CcSEcCtD
Lorazepam—Rash—Epirubicin—ovarian cancer	0.000481	0.000564	CcSEcCtD
Lorazepam—Dermatitis—Epirubicin—ovarian cancer	0.000481	0.000564	CcSEcCtD
Lorazepam—Headache—Epirubicin—ovarian cancer	0.000478	0.000561	CcSEcCtD
Lorazepam—Dizziness—Doxorubicin—ovarian cancer	0.000467	0.000547	CcSEcCtD
Lorazepam—Midazolam—ABCB1—ovarian cancer	0.000459	0.0582	CrCbGaD
Lorazepam—Nausea—Epirubicin—ovarian cancer	0.000453	0.000531	CcSEcCtD
Lorazepam—Vomiting—Doxorubicin—ovarian cancer	0.000449	0.000526	CcSEcCtD
Lorazepam—Rash—Doxorubicin—ovarian cancer	0.000445	0.000522	CcSEcCtD
Lorazepam—Dermatitis—Doxorubicin—ovarian cancer	0.000445	0.000522	CcSEcCtD
Lorazepam—Headache—Doxorubicin—ovarian cancer	0.000442	0.000519	CcSEcCtD
Lorazepam—Nausea—Doxorubicin—ovarian cancer	0.000419	0.000492	CcSEcCtD
Lorazepam—Diazepam—ABCB1—ovarian cancer	0.000393	0.0499	CrCbGaD
Lorazepam—Clozapine—ABCB1—ovarian cancer	0.000388	0.0493	CrCbGaD
